Release Date: 06/08/20 11:01 Summary: Ceasing to be a substantial holder from CBA Price Sensitive: No Download Document 174.52KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%